Operation Warp Speed Had Trouble Enrolling Patients In COVID-19 Therapeutic Research

US FDA Acting Commissioner Woodcock says there is ‘a long list’ of lessons learned in the OWS therapeutics group, noting trial bureaucracy and the lack of resources and support for community centers.

Clinical trials for COVID-19 therapeutics have encountered obstacles • Source: Alamy

While Operation Warp Speed advanced several COVID-19 vaccine candidates, it faced numerous hurdles on the therapeutics side, including the ability to enroll patients in clinical trials.

“We had tens of thousands of people dying and we couldn’t enroll patients because we were relying on networks that...